FDA NDC Directory · JSON-LD · Markdown

signature care allergy relief

NDC 21130-301 · HUMAN OTC DRUG · TABLET, ORALLY DISINTEGRATING

Generic nameloratadine
Labeler / ManufacturerSafeway
Marketing categoryAbbreviated NDA (generic) · App ANDA076011
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsLORATADINE (10 mg/1)
Marketing started20200626
Package count1

External sources

Source: openFDA. Public-domain (CC0).